Skip to main content

Synergus

  • Home
  • About
    • Our Publications
    • Employment Opportunities
    • Intern/Thesis Opportunities
    • Find Us
    • Privacy Policy
    • Contact Us
    • IGES group
  • RWE impact
    • Data that makes the difference
    • Real World Data / Statistical analysis
    • Evidence For Decisions
  • Market Access
    • Countries
    • Diagnostics
    • Digital Health
    • Medical Device
      • Market access strategy
      • Hands-on market access support
      • Reimbursement dossier / HTA dossier
      • Reimbursement/DRG analysis
    • Pharma
  • HEOR
    • Health Economics
      • Cost Effectiveness and Budget Impact Modelling
      • Economic Outcomes in Clinical Studies
    • Value Demonstration
  • Events/Webinars
  • News
  • Blog

  • Home
  • About
    • Our Publications
    • Employment Opportunities
    • Intern/Thesis Opportunities
    • Find Us
    • Privacy Policy
    • Contact Us
  • RWE impact
    • Data that makes the difference
    • Real World Data / Statistical analysis
    • Evidence For Decisions
  • Market Access
    • Countries
    • Diagnostics
    • Digital Health
    • Medical Device
      • Market access strategy
      • Reimbursement/DRG analysis
      • Reimbursement dossier / HTA dossier
      • Hands-on market access support
    • Pharma
  • HEOR
    • Health Economics
      • Cost Effectiveness and Budget Impact Modelling
      • Economic Outcomes in Clinical Studies
    • Value Demonstration
  • Events/Webinars
  • News
  • Blog

Blog

Close to 400 diagnostic and digital health solutions to fight COVID-19, how we do select the right one?
26 Mar 2020

Tags:
COVID-19
read more
Solutions to fight the COVID-19 pandemic
20 Mar 2020

Tags:
Corona virus
read more
What is the status of diagnostic and digital health solutions to fight the corona pandemic?
19 Mar 2020

Tags:
Corona virus
read more
Status update: Digital Health Frameworks in Europe
10 Mar 2020

We are continuing 

Tags:
HTA
read more
How will the payer view the value of a digital solution in Germany?
28 Feb 2020

Tags:
GermanyDigital HealthDHS Germany
read more
Evaluation of assessment methodologies by HTA’s specific to Digital Health in Europe
21 Feb 2020

Tags:
Digital Health
read more
The French program for telemedicine / digital health – Analysis of development
14 Feb 2020

Tags:
Digital HealthFranceDHS France
read more
Internship report about the use of data science in Oncology
31 Jan 2020

Tags:
Data Science in Oncology
read more
Introduction of national collaboration regarding medical devices in Sweden
29 Jan 2020

Tags:
SwedenMedical Device
read more
Can RWE contribute to investigate and contain the current outbreak of novel coronavirus?
24 Jan 2020

Tags:
ChinaReal World EvidenceCorona virus
read more
  • Show More

Contact us

Tags

Breast cancer
Corona virus
DHS France
EMA
EQ-5D
EU HTAR
EU HTAR IVD
EU HTAR Medtech
Germany
HQ_RWD
Imaging
Myeloma
Obesity
Patient Registries
Pharma
RWD Scientific Impact
RWD_DK
Transferability of Outcomes
Coverage with Evidence Development
DHS Germany
Italy
Melanoma
Multiple Sclerosis
Quality of Life
R-RCT
Registries
SF-36
DHS Belgium
Funding
HQRWE_Fracture
Netherlands
Rheumatoid Arthritis
Throat Cancer
Co-payment
Empowered Patients
Lung Cancer
Norway
Stroke
Digital Heath Strategies
France
Innovation Funding
Mental Health
Data Science in Oncology
Finland
Heart Failure
Out-patient procedures
Artificial Intelligence
Denmark
Diabetes
Dementia
Sweden
Alzheimer
The Netherlands
Oncology
United Kingdom
Country specific
China
COVID-19
Value Based Healthcare
HTA
RefugeeMD
Medical Device
Disease Specific
Health Economics
Legislation
Market Access
IVD
Digital Health
Real World Data
Real World Evidence
  • Home
  • About
  • RWE impact
  • Market Access
  • HEOR
  • Events/Webinars
  • News
  • Blog